openPR Logo
Press release

Factor V leiden and prothrombin G20210A mutations may predispose for cerebral infarction

05-24-2012 07:41 PM CET | Health & Medicine

Press release from: Pabst Science Publishers

A recent age- and sex-matched paired case-control study comparing patients suffering from cerebral infarction with and without patent foramen ovale (PFO) revealed that the occurence of factor V leiden and, to a lesser extent, of prothrombin G20210 A mutation is a clinically relevant risk for the development of cerebral infarction in association with PFO.
Berhard Stephan and his team at the University Hospitals of Saarland, Homburg (Germany) studied a total of 92 patients with ischemic stroke, 46 individuals with and 46 without patent foramen ovale (PFO). The frequency of factor V leiden was 2.1 fold higher in PFO patients than in subjects without PFO which was significant. Prothrombin mutation in PFO patients was observed in 3 versus 1 case which was not significant. Combined presence of these two kinds of mutations was not observed in any of the cases.
Due to the close relationship of these markers with the formation of venous thrombosis, the data provide further evidence that paradoxical embolism is obviously an essential mechanism for developing stroke in PFO patients. Stephan et al., in their report published in Applied Cardiopulmonary Pathophysiology 16 (No 1-2012), suggest to perform additional examinations of the peripheral venous system in stroke patients with PFO and inherited thrombophilia – apart from neurological and cardiologic diagnosis.

Bernhard Stephan et al.: Clinical significance of factor V G1691A and prothrombin G20210A mutations in cerebral infarction and patent foramen ovale. In: Applied Cardiopulmonary Pathophysiology 16; 32-36, 2012. Pabst, Lengerich/Berlin/Wien

Pabst Science Publishers (Lengerich/Westfalia, Germany) is publishing ten psychological and nine medical journals; furthermore, Pabst is publishing more than hundred psychological and medical books per year – partly specialized scientific literature, partly specialist literature written for laypeople.

Pabst Science Publishers
Eichengrund 28
49525 Lengerich
Tel. 05484-308
Fax 05484-550
E-Mail: pabst.publishers@t-online.de
Internet: www.pabst-science-publishers.com / www.applied-cardiopulmonary-pathophysiology.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Factor V leiden and prothrombin G20210A mutations may predispose for cerebral infarction here

News-ID: 222504 • Views: 2083

More Releases from Pabst Science Publishers

Health literacy: How to improve health behaviors
Health literacy is defined as "people´s knowledge, motivation and competences to access, understand, appraise and apply information to make judgements and take decisions in everyday life healthcare concerning disease prevention and health promotion to maintain and improve quality of life during the life course." In a new volume Anne-Kathrin Mayer and colleagues shed light on the concept of health literacy from different disciplines: psychology, educational sciences, health sciences and
Health literacy: how to improve the advantages and to reduce the risks
The new volume "Health literacy across the lifespan" stresses the importance of health literacy for changing multiple health-risk-factors. Anne-Kathrin Mayer and colleagues shed light on a concept from different disciplines: psychology, educational sciences, health sciences and public health, communication sciences, and information sciences. It is undisputed that health is strongly influenced by individual efforts aimed at the promotion of health and the prevention of illness or recovery from diseases. These
Directed deceased donation: beyond the impartial allocation system
"Within a pluralistic account of morality, partial values have a merit of their own and should be assessed in their own terms. These values are extremely relevant in the field of organ transplantation, but are misunderstood at a political level where partiality is put at par with injustice, and where fairness is exclusively taken as impartial justice." Dr. Medard Hilhorst (Erasmus Medical University Rotterdam) argues "that partial values are fundamental
Transplantation: Prisoners are killed for their organs in China
Transplantation: China is the only country in the world systematically using organs from prisoners for transplantation, Professor Huige Li reports. For over 40 years, executed prisoners were used as the main organ source in China. It´s a profitable international business. A number of Chinese Hospitals claimed that they could provide liver transplants in the time range between 3 to 30 days. The report appeared in "Ethical, Legal and Psychosocial Aspects

All 5 Releases


More Releases for PFO

PFO Closure Device Market - Notable Developments, Worldwide Opportunities & Futu …
PFO Closure Device Market (5 Year Forecast 2019-2025) report provides market Overview, Classification, Industry Value, Price, Cost and Gross Profit.  It also offers in-intensity insight of the PFO Closure Device industry masking all vital parameters along with Drivers, Market Trends, Market Dynamics, Opportunities, Competitive Landscape, New Challenge Feasibility Evaluation, PFO Closure Device market Share via Region, Analysis and Guidelines on New mission Investment. PFO Closure Device industry report also provides previous 5 Year History with a
PFO Closure Device Market Report 2018: Segmentation by Type (Amplatzer PFO Occlu …
Global PFO Closure Device market research report provides company profile for W. L. Gore & Associates, Cardia, LifeTech, Abbott, Occlutech, Starway and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
PFO Closure Devices Market to Perceive Substantial Growth During 2018–2026
Patent Foramen Ovale (PFO) is a hole in the heart, which can be cured by filling in the gap, using PFO closure devices. PFOs only occur after birth due to closure failure of the foramen ovale. This hole allows blood to pass through the fetal lungs, which cannot work until exposed to air. Foramen ovale usually closes after a newborn takes its first breath and in 75 percent of individuals it
Patent Foramen Ovale (PFO) Closure Devices Market - Size, Share, Outlook, 2026
Patent Foramen Ovale (PFO) is a medical condition wherein tissue flap in the wall between left and right atrium remains persistently open, allowing a small amount of blood to pass from the right side of the heart to the left side of the heart. PFO closure device are implantable device used to treat PFO through a minimally invasive, catheter-based technique, implicated in a number of pathological states, including cryptogenic strokes,
Patent Foramen Ovale (PFO) Closure Devices Market analysis 2026
Patent Foramen Ovale (PFO) is a medical condition wherein tissue flap in the wall between left and right atrium remains persistently open, allowing a small amount of blood to pass from the right side of the heart to the left side of the heart. PFO closure device are implantable device used to treat PFO through a minimally invasive, catheter-based technique, implicated in a number of pathological states, including cryptogenic strokes,
Global PFO Closure Device Market Poised to Take Off by 2023
Worldwide Market Reports added Latest Research Report titled ” Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) PFO Closure Device Market 2018 Forecast to 2023 ” to its Large Report database. Patent Foramen Ovale (PFO), A hole in your heart would seem to be the very definition of a “problem.” Yet more than a quarter of the population has one, and for most it causes no adverse